8 Best Small-Cap Value Stocks to Buy According to Analysts
On March 25, Jill Carey Hall, the head of US small and mid-cap strategy at B&A Securities, appeared on CNBC television to discuss the performance of the sector.
Perrigo Co Plc (PRGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 2,481,711 | $34,545,417 | +39% | 0.18% |
| 2. | Millennium Management Israel Englander | 2,121,710 | $29,534,203 | -34% | 0.01% |
| 3. | Citadel Investment Group Ken Griffin | 1,357,884 | $18,901,745 | +644% | 0% |
| 4. | GAMCO Investors Mario Gabelli | 1,077,785 | $15,002,767 | +26% | 0.14% |
| 5. | Quantinno Capital Hoon Kim | 662,337 | $9,219,732 | +333% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.18 | 7,500 | $106,350.00 | 17,375 | 2025-11-12 | Filing | |
| $22.41 | 1,255 | $28,124.55 | 1,255 | 2025-09-08 | Filing | |
| $23.20 | 1,000 | $23,200.00 | 1,000 | 2025-09-05 | Filing | |
| $24.10 | 1,488 | $35,857.82 | 41,939 | 2025-08-22 | Filing | |
| $22.97 | 4,375 | $100,497.25 | 9,875 | 2025-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.44 | 7,800 | $214,032.00 | 33,666 | 2025-03-10 | Filing | |
| $28.27 | 17,598 | $497,495.46 | 5,409 | 2024-12-09 | Filing | |
| $27.30 | 8,954 | $244,444.20 | 6,009 | 2024-09-13 | Filing | |
| $29.40 | 13,000 | $382,245.50 | 20,553 | 2024-08-26 | Filing | |
| $27.43 | 6,683 | $183,281.28 | 7,000 | 2024-08-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 733,294 | $7,875,575 | 1.95% | |
| 2. | 9,306 | $99,946 | 0% | |
| 3. | 4,520 | $49,718 | 0% | |
| 4. | 3,043 | $32,682 | 0% | |
| 5. | 2,472 | $26,549 | 0.01% |
News See All
Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business
On February 27, Canaccord analyst Susan Anderson lowered the firm’s price recommendation on Perrigo Company plc (NYSE:PRGO) to $17 from $20. It reiterated a Buy rating on the shares.
13 Extreme Dividend Stocks With Huge Upside Potential
Dividend stocks have outperformed the market so far this year. The S&P 500 Dividend Aristocrat Index has risen nearly 3% since the start of 2026.
Perrigo Company plc (NYSE:PRGO) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Perrigo Q4 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, February 26, 2026.
Perrigo (PRGO) Target Reduced as JPMorgan Refreshes Estimates
On December 15, JPMorgan lowered its price target on Perrigo Company plc (NYSE:PRGO) to $18 from $20 and kept a Neutral rating on the stock.
Dividend Achievers List: Top 16 Stocks
In a market that feels unsettled more often than not, many investors are looking for ways to smooth the ride without giving up growth.
Should You Hold Your Stake in Perrigo Company, plc (PRGO)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Canaccord Maintains Buy on Perrigo (PRGO) While Cutting Price Target to $20
On November 6, Canaccord lowered its price target on Perrigo Company plc (NYSE:PRGO) to $20 from $40, while maintaining a Buy rating on the stock, as reported by The Fly.
15 Best 52-Week Low Dividend Stocks to Invest In
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks in terms of popularity.
Perrigo (PRGO) Falls to 52-Week Low on Weak Sales, Infant Formula Review
Perrigo fell to a new 52-week low on Wednesday, extending to a three-day losing streak, as investor sentiment was dampened by weak net sales and news that it was conducting a strategic review of its infant...
Hedge Fund Resource Center